0:00 / 0:00

Medical Expertise

Dr. Dean Fennell
Dr. Dean Fennell. Mesothelioma treatment expert. Biography. 0

1. Dr. Dean Fennell. Mesothelioma treatment expert. Biography. 0

Dr. Dean Fennell, MD, explains his extensive background in cancer research. He is a Professor of Thoracic Medical Oncology at the University of Leicester.

Mesothelioma symptoms. Causes of Mesothelioma. 1

2. Mesothelioma symptoms. Causes of Mesothelioma. 1

Dr. Dean Fennell, MD, explains the causes, symptoms, and diagnosis of this rare cancer. Mesothelioma is a cancer of the lining of the chest or...

Genetic mutations in mesothelioma. Is early diagnosis of mesothelioma possible? 2

3. Genetic mutations in mesothelioma. Is early diagnosis of mesothelioma possible? 2

Dr. Dean Fennell, MD, explains the unique molecular signature of this aggressive cancer. He details the three most common genetic alterations found in mesothelioma patients....

Mesothelioma diagnostic tests. Staging. Agnostic treatment strategy. 3

4. Mesothelioma diagnostic tests. Staging. Agnostic treatment strategy. 3

Dr. Dean Fennell, MD, explains how diagnostic tests guide treatment selection. Histology is critical for prognosis and therapy decisions. Epithelial mesothelioma has a better outcome...

Mesothelioma. Surgical treatment options. 4

5. Mesothelioma. Surgical treatment options. 4

Dr. Dean Fennell, MD, explains the complex role of surgery in treating this aggressive cancer. He details how patient selection is critical, as some mesothelioma...

Mesothelioma. Radiotherapy. 5

6. Mesothelioma. Radiotherapy. 5

Dr. Dean Fennell, MD, explains the role of radiotherapy in treating this aggressive cancer. He details the findings of key clinical trials that have shaped...

Mesothelioma. Chemotherapy and immunotherapy. 6

7. Mesothelioma. Chemotherapy and immunotherapy. 6

Dr. Dean Fennell, MD, explains the evolution of systemic therapy for this aggressive cancer. He details the historical standard of pemetrexed with platinum chemotherapy.

Mesothelioma. CAR T-cell therapy. Tumor Treating Fields 
(TT Fields). 7

8. Mesothelioma. CAR T-cell therapy. Tumor Treating Fields 
(TT Fields). 7

Dr. Dean Fennell, MD, explains the latest treatment advances. He discusses the potential of CAR T-cell therapy targeting mesothelin.

Mesothelioma stratified therapy clinical trials (MiST). 8

9. Mesothelioma stratified therapy clinical trials (MiST). 8

Dr. Dean Fennell, MD, explains the innovative Mesothelioma Stratified Therapy (MiST) clinical trial program. This master protocol tests multiple targeted treatments simultaneously in biomarker-selected patient...

Future in mesothelioma treatment. 9

10. Future in mesothelioma treatment. 9

Dr. Dean Fennell, MD, explains the future of systemic therapy for this aggressive cancer. He highlights the increasing pace of drug development and the discovery...

Mesothelioma. Importance 
for patients of enrollment into clinical trials. 10

11. Mesothelioma. Importance 
for patients of enrollment into clinical trials. 10

Dr. Dean Fennell, MD, explains the critical importance of clinical trials for patients. He addresses common patient questions about prognosis and survival.

Mesothelioma. Clinical case. Example of importance of enrollment into clinical trials. 11

12. Mesothelioma. Clinical case. Example of importance of enrollment into clinical trials. 11

Dr. Dean Fennell, MD, explains the critical importance of clinical trials for advanced treatment. He shares a compelling clinical case where a novel PARP inhibitor...